article thumbnail

Cybersecurity in pharma: Securing the future

Pharmaceutical Technology

Cybersecurity challenges As per a Healthcare Information and Management Systems Society (HIMSS) 2022 survey, there is a need for greater awareness on Health Insurance Portability and Accountability Act (HIPAA) and data privacy along with other measures. Pharmaceutical companies that are publicly traded will need to pay attention,” warns Kim.

HIPAA 110
article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Given the public health emergency, health authorities offered greater flexibilities in the use of digital health platforms and technologies such as: Enhanced HIPAA (Health Insurance Portability and Accountability Act of 1996) flexibilities in the use of telemedicine services 3. Is the software MDSW according to MDCG 2019-11?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

However, for certain DHTs classified as devices or SaMD, ISO 14971:2019 specifies the terminology, principles, and process for application of risk management. Is the product “software” according to the definition of MDCG 2019-11? Is the product “software” according to the definition of MDCG 2019-11? Published 26 September 2019.

article thumbnail

Ep. 007 – Holly Henry and Kamran Shah Podcast Transcript

Pharma Marketing Network

When you think of healthcare, from a HIPAA standpoint like tying everything back just like an individual does, you know start drawing some boundaries. Kamran (KH): I think one thing I always think of is the pharmaceutical industry is probably more privacy minded than most just because of HIPAA and other regulations we have to work under.

HIPAA 40